BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32209881)

  • 1. Pulmonary Cryptococcosis Accidentally Detected by 68Ga-Pentixafor PET/CT in a Patient With Multiple Myeloma.
    Pan Q; Luo Y; Cao X; Li J; Li F
    Clin Nucl Med; 2020 May; 45(5):423-425. PubMed ID: 32209881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Uptake of 68Ga-Pentixafor in Thymic Rebound After Chemotherapy in a Patient With Multiple Myeloma.
    Pan Q; Luo Y; Cao X; Li J
    Clin Nucl Med; 2021 Jan; 46(1):90-92. PubMed ID: 33181744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT.
    Pan Q; Luo Y; Cao X; Ma Y; Li F
    Clin Nucl Med; 2018 Jun; 43(6):462-463. PubMed ID: 29538035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor-4 targeted PET/CT with
    Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68Ga-Pentixafor PET/CT Improves the Detection of Recurrent Myeloma in the Temporal Bone Masked by the Physiological 18F-FDG Uptake of the Brain and Extraocular Muscles.
    Pan Q; Luo Y; Cao X; Li J
    Clin Nucl Med; 2022 Apr; 47(4):e348-e350. PubMed ID: 35020649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine Receptor 4-Targeted PET/CT With 68 Ga-Pentixather Detects More Lesions Than 68 Ga-Pentixafor PET/CT in Multiple Myeloma.
    Yang Q; Zhang F; Hao Z; Zhuang J; Huo L
    Clin Nucl Med; 2024 Jun; 49(6):592-593. PubMed ID: 38630995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Chen Z; Yang A; Chen A; Dong J; Lin J; Huang C; Zhang J; Liu H; Zeng Z; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1926-1936. PubMed ID: 38286937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced splenic uptake on
    Kraus S; Klassen P; Kircher M; Dierks A; Habringer S; Gäble A; Kortüm KM; Weinhold N; Ademaj-Kospiri V; Werner RA; Schirbel A; Buck AK; Herhaus P; Wester HJ; Rosenwald A; Weber WA; Einsele H; Keller U; Rasche L; Lapa C
    Theranostics; 2022; 12(13):5986-5994. PubMed ID: 35966583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
    Luo Y; Pan Q; Feng J; Cao X; Li F
    Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
    Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
    J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
    [No Abstract]   [Full Text] [Related]  

  • 12. Posttreated POEMS Syndrome With Concurrent Follicular Lymphoma Revealed by 18F-FDG and 68Ga-Pentixafor PET/CT.
    Pan Q; Luo Y; Cao X; Li J; Li F
    Clin Nucl Med; 2020 Mar; 45(3):220-222. PubMed ID: 31977484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on
    Xu L; Tetteh G; Lipkova J; Zhao Y; Li H; Christ P; Piraud M; Buck A; Shi K; Menze BH
    Contrast Media Mol Imaging; 2018; 2018():2391925. PubMed ID: 29531504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT.
    Kuyumcu S; Yilmaz E; Büyükkaya F; Özkan ZG; Ünal SN
    Clin Nucl Med; 2018 Aug; 43(8):606-608. PubMed ID: 29916918
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Bouter C; Meller B; Sahlmann CO; Staab W; Wester HJ; Kropf S; Meller J
    J Nucl Med; 2018 Feb; 59(2):320-326. PubMed ID: 28729430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging Inflammation in Atherosclerosis with CXCR4-Directed
    Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X
    J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
    Herrmann K; Lapa C; Wester HJ; Schottelius M; Schiepers C; Eberlein U; Bluemel C; Keller U; Knop S; Kropf S; Schirbel A; Buck AK; Lassmann M
    J Nucl Med; 2015 Mar; 56(3):410-6. PubMed ID: 25698782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Residual Tumor With 68Ga-Pentixafor PET/CT in a Patient With Waldenström Macroglobulinemia and Concurrent John Cunningham Virus-Related Progressive Multifocal Leukoencephalopathy.
    Pan Q; Luo Y; Qian M
    Clin Nucl Med; 2020 Oct; 45(10):792-794. PubMed ID: 32804761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [
    Haug AR; Leisser A; Wadsak W; Mitterhauser M; Pfaff S; Kropf S; Wester HJ; Hacker M; Hartenbach M; Kiesewetter-Wiederkehr B; Raderer M; Mayerhoefer ME
    Theranostics; 2019; 9(12):3653-3658. PubMed ID: 31281504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkitt Lymphoma/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET/CT.
    Chen Z; Xue Q; Huang C; Yao S; Miao W
    Clin Nucl Med; 2022 Jan; 47(1):98-100. PubMed ID: 34115701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.